BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21454988)

  • 1. Vascular calcification in patients with chronic kidney disease: types, clinical impact and pathogenesis.
    Román-García P; Rodríguez-García M; Cabezas-Rodríguez I; López-Ongil S; Díaz-López B; Cannata-Andía JB
    Med Princ Pract; 2011; 20(3):203-12. PubMed ID: 21454988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes.
    Cannata-Andía JB; Rodríguez-García M; Carrillo-López N; Naves-Díaz M; Díaz-López B
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S267-73. PubMed ID: 17130273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.
    Caudrillier A; Mentaverri R; Brazier M; Kamel S; Massy ZA
    J Nephrol; 2010; 23(1):17-22. PubMed ID: 20091482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
    Koizumi M; Fukagawa M
    Clin Calcium; 2010 Nov; 20(11):1700-8. PubMed ID: 21037391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular calcification in patients with chronic kidney disease.
    Nitta K
    Ther Apher Dial; 2011 Dec; 15(6):513-21. PubMed ID: 22107687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.
    Toussaint ND; Kerr PG
    Nephrology (Carlton); 2007 Oct; 12(5):500-9. PubMed ID: 17803475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Atheroma and vascular calcification in hemodialysis patients].
    Joki N; Tanaka Y
    Clin Calcium; 2010 Jul; 20(7):1061-6. PubMed ID: 20585185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of treatment with calcimimetics on hyperparathyroidism and vascular mineralization.
    de Francisco AL; Piñera C; Palomar R; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S281-5. PubMed ID: 17130275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of hyperphosphatemia in vascular calcification].
    Shioi A; Nishizawa Y
    Clin Calcium; 2009 Feb; 19(2):180-5. PubMed ID: 19182356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular calcification in chronic kidney disease: mechanisms and clinical implications.
    Ossareh S
    Iran J Kidney Dis; 2011 Sep; 5(5):285-99. PubMed ID: 21876304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
    Sigrist MK; Taal MW; Bungay P; McIntyre CW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular calcification and bone disease: the calcification paradox.
    Persy V; D'Haese P
    Trends Mol Med; 2009 Sep; 15(9):405-16. PubMed ID: 19733120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated mineral metabolism in children with chronic kidney disease.
    Shroff R
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):233-40. PubMed ID: 21422924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mediators of vascular damage in dialysed patients.
    Checheriţă IA; David C; Stoica L; Popescu P; Ciocâlteu A; Lascăr I
    Rom J Morphol Embryol; 2011; 52(2):533-6. PubMed ID: 21655639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of vascular calcification in CKD patients.
    Massry SG; Smogorzewski M
    Semin Nephrol; 2006 Jan; 26(1):38-41. PubMed ID: 16412824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metabolism, vascular calcifications and mortality: associations beyond mere coincidence.
    Rodriguez Garcia M; Naves Diaz M; Cannata Andia JB
    J Nephrol; 2005; 18(4):458-63. PubMed ID: 16245255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification in uremic conditions: new insights into pathogenesis.
    Cozzolino M; Gallieni M; Brancaccio D
    Semin Nephrol; 2006 Jan; 26(1):33-7. PubMed ID: 16412823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.